Lawrence K Fung

Design, synthesis and evaluation of constrained tetrahydroimidazopyrimidine derivatives as antagonists of corticotropin-releasing factor type 1 receptor (CRF1R).

K. Browman, J. Macor, G. Dubowchik, 2010, Bioorganic & medicinal chemistry letters.

Aminoquinazolines as TRPV1 antagonists: modulation of drug-like properties through the exploration of 2-position substitution.

Mark T. Kershaw, J. Chandrasekhar, J. Krause, 2008, Bioorganic & medicinal chemistry letters.

Synthesis and structure-activity relationship of imidazo[1,2-a]benzimidazoles as corticotropin-releasing factor 1 receptor antagonists.

Stella Huang, G. Dubowchik, S. Pin, 2005, Bioorganic & medicinal chemistry letters.

Shift in pH of biological fluids during storage and processing: effect on bioanalysis.

A. Fura, Hongjiang Zhang, W. Shyu, 2003, Journal of pharmaceutical and biomedical analysis.

Synthesis, structure-activity relationships, and anxiolytic activity of 7-aryl-6,7-dihydroimidazoimidazole corticotropin-releasing factor 1 receptor antagonists.

K. Browman, G. Dubowchik, S. Pin, 2005, Bioorganic & medicinal chemistry letters.

2-arylaminothiazoles as high-affinity corticotropin-releasing factor 1 receptor (CRF1R) antagonists: synthesis, binding studies and behavioral efficacy.

K. Browman, D. Zuev, P. Scola, 2003, Bioorganic & medicinal chemistry letters.

Discovery of N-(1-ethylpropyl)-[3-methoxy-5-(2-methoxy-4-trifluoromethoxyphenyl)-6-methyl-pyrazin-2-yl]amine 59 (NGD 98-2): an orally active corticotropin releasing factor-1 (CRF-1) receptor antagonist.

Ping Ge, Taeyoung Yoon, Dario Doller, 2011, Journal of medicinal chemistry.